Kaustubh Bhardwaj, “FUTURE CHALLENGES AND EMERGING SAFETY CONCERNS OF GLP-1 RECEPTOR AGONISTS, DUAL INCRETIN AGONISTS, AND SGLT2 INHIBITORS”, J Popl Ther Clin Pharmacol, vol. 33, no. 2, pp. 963–981, Jun. 2026, doi: 10.69980/mng8r305.